A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis

Trial Profile

A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Actinic keratosis
  • Focus Adverse reactions
  • Sponsors Medicis Pharmaceutical Corporation
  • Most Recent Events

    • 24 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 20 Apr 2012 Planned end date changed from 1 Jan 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
    • 12 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top